Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: MediaZest Soars As Kicks Off 2021 With Deal Wins

Thu, 11th Feb 2021 11:21

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

MediaZest, more than trebled to 0.16 pence, 12-month range 0.0150p-0.1788p. The audio visual services firm has made a strong start to calendar year 2021, sealing new business wins. In total, new business wins will generate over GBP350,000 in revenue. The stock had closed at 0.050p on Wednesday.

----------

Clear Leisure, up 68% at 1.15 pence, 12-month range 0.110p-1.365p. The company seals GBP680,000 of extra cash through a placing of 113.3 million shares at 0.60 pence each. The technology sector-focused investor will use the funds for working capital and for "selective" further investments.

----------

N4 Pharma, up 14% at 9.24 pence, 12-month range 2.00p-16.00p. The Derbyshire-based pharmaceutical company reports the European Commission intends to grant a patent for Nuvec, a potential cancer treatment. N4 has "exclusive worldwide rights" for Nuvec.

----------

AIM - LOSERS

----------

Europa Oil & Gas, down 18% at 1.35p, 12-month range 0.550p-2.100p. The UK, Ireland and Morocco-focused oil and gas explorer plans to raise GBP2 million through a placing and broker option, priced at 1.3p per share, a 21% discount to its 1.65p closing price on Wednesday. Funds will go towards furthering its UK fields, the Inezgane licence in Morocco and "evaluating late-stage appraisal/development projects".

----------

Eden Research, down 7.8% at 13.77p, 12-month range 4.42p-17.00p. The plastic-free formulation technology company expects revenue for 2020 to come in at GBP1.6 million, a 20% fall, with its pretax loss stretching to GBP2.6 million from GBP1.4 million.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Jun 2018 11:54

N4 Pharma Says Team Making Progress In Nuvec Manufacturing Process

LONDON (Alliance News) - Drug reformulator N4 Pharma PLC said Monday work to develop a manufacturing process for Nuvec has begun "well" with the team making progress.Nuvec is a to

Read more
9 May 2018 14:13

N4 Pharma Files Patent For Drug To Treat Premature Ejaculation

LONDON (Alliance News) - Pharmaceutical company N4 Pharma PLC announced on Wednesday it has filed a patent application for a treatment for premature ejaculation.N4 Pharm's drug is an of

Read more
25 Apr 2018 11:54

N4 Pharma Outlook Optimistic But Loss Widens After Reverse Takeover

LONDON (Alliance News) - N4 Pharma PLC on Wednesday said it remains optimistic for future as progresses its drug and vaccine development, but the company's loss widened in 2017 following its a

Read more
18 Apr 2018 12:15

N4 Pharma Starts Clinical Trial Of Reformulated Sildenafil

LONDON (Alliance News) - N4 Pharma PLC said Wednesday that it has commenced proof of concept clinical trial for erectile dysfunction treatment drug sildenafil, following the completion of the of a

Read more
9 Mar 2018 10:43

N4 Pharma Raises Nets GBP159,700 From Warrant Exercise (ALLISS)

LONDON (Alliance News) - N4 Pharma PLC said Friday it issued 1.9 million shares due to exercise of warrants, raising GBP159,700 for the pharmaceutical warrants

Read more
8 Mar 2018 13:34

N4 Pharma Unveils Two-Pronged Strategy For Nuvec Development

LONDON (Alliance News) - N4 Pharma PLC announced Thursday a two-fold development strategy for its Nuvec technology, as well as a new head of development for Nuvec.Nuvec

Read more
7 Mar 2018 12:41

N4 Pharma Raises Further GBP30,451 After Warrant Exercise (ALLISS)

LONDON (Alliance News) - N4 Pharma PLC said Wednesday it issued 358,245 shares due to exercise of warrants, raising GBP30,451 for the pharmaceutical warrants at

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.